Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016
Beeton, Michael L.
Uldum, Søren A.
Spiller, O. Brad
Chalker, Victoria J.
ESCMID Study Group for Mycoplasma and Chlamydia Infections (ESGMAC) Mycoplasma pneumoniae sub-group
European Centre for Disease Prevention and Control
MetadataShow full item record
Background: Mycoplasma pneumoniae is a leading cause of community-acquired pneumonia, with large epidemics previously described to occur every 4 to 7 years. Aim: To better understand the diagnostic methods used to detect M. pneumoniae; to better understand M. pneumoniae testing and surveillance in use; to identify epidemics; to determine detection number per age group, age demographics for positive detections, concurrence of epidemics and annual peaks across geographical areas; and to determine the effect of geographical location on the timing of epidemics. Methods: A questionnaire was sent in May 2016 to Mycoplasma experts with national or regional responsibility within the ESCMID Study Group for Mycoplasma and Chlamydia Infections in 17 countries across Europe and Israel, retrospectively requesting details on M. pneumoniae-positive samples from January 2011 to April 2016. The Moving Epidemic Method was used to determine epidemic periods and effect of country latitude across the countries for the five periods under investigation. Results: Representatives from 12 countries provided data on M. pneumoniae infections, accounting for 95,666 positive samples. Two laboratories initiated routine macrolide resistance testing since 2013. Between 2011 and 2016, three epidemics were identified: 2011/12, 2014/15 and 2015/16. The distribution of patient ages for M. pneumoniae-positive samples showed three patterns. During epidemic years, an association between country latitude and calendar week when epidemic periods began was noted. Conclusions: An association between epidemics and latitude was observed. Differences were noted in the age distribution of positive cases and detection methods used and practice. A lack of macrolide resistance monitoring was noted.
Beeton, M.L., Zhang, X.S., Uldum, S.A., Bébéar, C., Dumke, R., Gullsby, K., Ieven, M., Loens, K., Nir-Paz, R., Pereyre, S. and Spiller, O.B. (2020) 'Mycoplasma pneumoniae infections, 11 countries in Europe and Israel, 2011 to 2016', Eurosurveillance, 25(2), p.1900112.
Article published in Eurosurveillance on 16 January 2020 (online), available open access at: https://doi.org/10.2807/1560-7917.ES.2020.25.2.1900112.
Cardiff Metropolitan University (Grant ID: Cardiff Metropolian (Internal))
Showing items related by title, author, subject and abstract.
Molecular exploration for Mycoplasma amphoriforme, Mycoplasma fermentans and Ureaplasma spp. from patient samples previously investigated for Mycoplasma pneumoniae infection Rehman, Safi; Day, Jessica; Afshar, Baharak; Rowlands, Richard S.; Billam, Harriet; Joseph, Amelia; Guiver, Malcolm; Maddocks, Sarah; Chalker, Victoria; Beeton, Michael L. (Elsevier, 2021-06-27)Objectives: To determine the presence and genotypic macrolide susceptibility of Mycoplasma amphoriforme, and presence of Ureaplasma spp., and Mycoplasma fermentans among clinical samples from England previously ...
Antibiotic resistance among clinical Ureaplasma isolates recovered from neonates in England and Wales between 2007 and 2013 Beeton, Michael L.; Chalker, Victoria J.; Jones, Lucy C.; Maxwell, Nicola C.; Spiller, O. Brad (American Society for Microbiology, 2015)Ureaplasma spp. are associated with numerous clinical sequelae with treatment options being limited due to patient and pathogen factors. This report examines the prevalence and mechanisms of antibiotic resistance among ...
Beeton, Michael L.; Spiller, Owen (Oxford University Press, 2016-10-20)There is growing global concern regarding the rise of antibiotic-resistant organisms. Many of these reports have focused on various Gram-positive and Gram-negative pathogens, with little attention to the genus Ureaplasma. ...